105 related articles for article (PubMed ID: 25966185)
1. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and the risk of breast carcinoma.
Zhong JH; Li LQ; Mo XS; Gong WF; Ma L; Chen J; You XM
Genet Mol Res; 2015 Apr; 14(2):4133-41. PubMed ID: 25966185
[TBL] [Abstract][Full Text] [Related]
2. Try113His and His139Arg polymorphisms in the microsomal epoxide hydrolase gene are not associated with risk of breast cancer.
Gong WF; He W; Zhang QM; Xiang BD; Ma L; Huang S; Bai T; Zhong JH; Li LQ
Tumour Biol; 2014 Aug; 35(8):8087-93. PubMed ID: 24840637
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma.
Zhong JH; Xiang BD; Ma L; You XM; Li LQ; Xie GS
PLoS One; 2013; 8(2):e57064. PubMed ID: 23451147
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between EPHX1 polymorphism and esophageal cancer risk: evidence from meta-analysis.
Yan YL; Chen X; Liang HJ; Wang J; Li TJ; Li RL; Li S; Qin X
Dis Esophagus; 2015; 28(2):164-71. PubMed ID: 25714851
[TBL] [Abstract][Full Text] [Related]
5. Association between esophageal cancer risk and EPHX1 polymorphisms: a meta-analysis.
Li QT; Kang W; Wang M; Yang J; Zuo Y; Zhang W; Su DK
World J Gastroenterol; 2014 May; 20(17):5124-30. PubMed ID: 24803829
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
[TBL] [Abstract][Full Text] [Related]
7. Impact of epoxide hydrolase 1 polymorphisms on lung cancer susceptibility in Asian populations.
Yu W; Lin Z; Qu B
Cell Biochem Biophys; 2015 Mar; 71(2):813-20. PubMed ID: 25312477
[TBL] [Abstract][Full Text] [Related]
8. Association between microsomal epoxide hydrolase 1 polymorphisms and susceptibility to esophageal cancer: a meta-analysis.
Zhao W; Luo J; Cai X
Tumour Biol; 2013 Aug; 34(4):2383-8. PubMed ID: 23681797
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis demonstrates lack of an association of microsomal epoxide hydrolase 1 polymorphisms with esophageal cancer risk.
Hu JJ; Wang ZT; Li B
Genet Mol Res; 2013 Oct; 12(4):4540-8. PubMed ID: 24222229
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of the effects of the EPHX1 Tyr113His polymorphism on lung and breast cancer.
Tan X; Wang YY; Chen XY; Xian L; Guo JJ; Liang GB; Chen MW
Genet Mol Res; 2014 Sep; 13(3):7437-46. PubMed ID: 25222243
[TBL] [Abstract][Full Text] [Related]
11. mEH Tyr113His polymorphism and the risk of ovarian cancer development.
Zhong JH; Zhang ZM; Li LQ
J Ovarian Res; 2013 Jun; 6(1):40. PubMed ID: 23742121
[TBL] [Abstract][Full Text] [Related]
12. EPHX1 Tyr113His and His139Arg polymorphisms in esophageal cancer risk: a meta-analysis.
Tan X; He WW; Wang YY; Shi LJ; Chen MW
Genet Mol Res; 2014 Jan; 13(1):649-59. PubMed ID: 24615030
[TBL] [Abstract][Full Text] [Related]
13. Association of Activity Altering Genotypes - Tyr113His and His139Arg in Microsomal Epoxide Hydrolase Enzyme with Esophageal Squamous Cell Carcinoma.
Nabi S; Bhat GA; Iqbal B; Lone MM; Lone GN; Khan MA; Dar NA
Nutr Cancer; 2019; 71(5):806-817. PubMed ID: 30633570
[TBL] [Abstract][Full Text] [Related]
14. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.
Liu F; Yuan D; Wei Y; Wang W; Yan L; Wen T; Xu M; Yang J; Li B
PLoS One; 2012; 7(8):e43821. PubMed ID: 22928041
[TBL] [Abstract][Full Text] [Related]
15. Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review.
Lee WJ; Brennan P; Boffetta P; London SJ; Benhamou S; Rannug A; To-Figueras J; Ingelman-Sundberg M; Shields P; Gaspari L; Taioli E
Biomarkers; 2002; 7(3):230-41. PubMed ID: 12141066
[TBL] [Abstract][Full Text] [Related]
16. Variability in human sensitivity to 1,3-butadiene: influence of polymorphisms in the 5'-flanking region of the microsomal epoxide hydrolase gene (EPHX1).
Abdel-Rahman SZ; Ammenheuser MM; Omiecinski CJ; Wickliffe JK; Rosenblatt JI; Ward JB
Toxicol Sci; 2005 May; 85(1):624-31. PubMed ID: 15716486
[TBL] [Abstract][Full Text] [Related]
17. Role of epoxide hydrolase 1 gene polymorphisms in esophageal cancer in a high-risk area in India.
Ihsan R; Chattopadhyay I; Phukan R; Mishra AK; Purkayastha J; Sharma J; Zomawia E; Verma Y; Mahanta J; Saxena S; Kapur S
J Gastroenterol Hepatol; 2010 Aug; 25(8):1456-62. PubMed ID: 20659238
[TBL] [Abstract][Full Text] [Related]
18. Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer.
Jain M; Tilak AR; Upadhyay R; Kumar A; Mittal B
Toxicol Appl Pharmacol; 2008 Jul; 230(2):247-51. PubMed ID: 18406439
[TBL] [Abstract][Full Text] [Related]
19. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer.
Zhou W; Thurston SW; Liu G; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):461-6. PubMed ID: 11352855
[TBL] [Abstract][Full Text] [Related]
20. Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses' Health Study and the Physicians' Health Study.
Tranah GJ; Chan AT; Giovannucci E; Ma J; Fuchs C; Hunter DJ
Mol Carcinog; 2005 Sep; 44(1):21-30. PubMed ID: 15924351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
